Quantitative systems-level determinants of human genes targeted by successful drugs

Genome Research

Volumn 18, Issue 2, 2008, Pages 206-213

  Yao, Lixia ^a   Rzhetsky, Andrey ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; GENE IDENTIFICATION; GENE INTERACTION; GENE TARGETING; HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

DRUG DELIVERY SYSTEMS; GENE EXPRESSION PROFILING; GENES; HUMANS; MODELS, THEORETICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

EID: 39049153521     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.6888208     Document Type: Article

References (31)

1. Adams, C.P. and Brantner, V.V. 2006. Estimating the cost of new drug development: Is it really 802 million dollars? Health Aff. (Millwood) 25: 420-428.
2. Alfarano, C., Andrade, C.E., Anthony, K., Bahroos, N., Bajec, M., Bantoft, K., Betel, D., Bobechko, B., Boutilier, K., Burgess, E., et al. 2005. The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res. 33: D418-D424.
3. Barabasi, A.L. and Bonabeau, E. 2003. Scale-free networks. Sci. Am. 288: 60-69.
4. Blake, J.A., Richardson, J.E., Bult, C.J., Kadin, J.A., and Eppig, J.T. 2003. MGD: The Mouse Genome Database. Nucleic Acids Res. 31: 193-195.
5. Bloom, J.D. and Adami, C. 2003. Apparent dependence of protein evolutionary rate on number of interactions is linked to biases in protein-protein interactions data sets. BMC Evol. Biol. 3: 21. doi: 10.1186/1471-2148-3-21.
6. Boyer, R.F. 2006. Concepts in biochemistry. Wiley, New York.
7. Drews, J. 2000. Drug discovery: A historical perspective. Science 287: 1960-1964.
8. Drews, J. 2003. Strategic trends in the drug industry. Drug Discov. Today 8: 411-420.
9. Drews, J. 2006. Case histories, magic bullets and the state of drug discovery. Nat. Rev. Drug Discov. 5: 635-640.
10. Drummond, D.A., Bloom, J.D., Adami, C., Wilke, C.O., and Arnold, F.H. 2005. Why highly expressed proteins evolve slowly. Proc. Natl. Acad. Sci. 102: 14338-14343.
11. Efron, B. 1982. The Jackknife, the Bootstrap and other resampling plans. Society for Industrial and Applied Mathematics, Philadelphia, PA.
12. Egner, U., Kratzschmar, J., Kreft, B., Pohlenz, H.D., and Schneider, M. 2005. The target discovery process. ChemBioChem 6: 468-479.
13. Fraser, H.B., Hirsh, A.E., Steinmetz, L.M., Scharfe, C., and Feldman, M.W. 2002. Evolutionary rate in the protein interaction network. Science 296: 750-752.
14. Hanley, J.A. and McNeil, B.J. 1982. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36.
15. Holme, P. and Kim, B.J. 2002. Growing scale-free networks with tunable clustering. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 65: 026107. doi: 10.1103/PhysRevE.65.026107.
16. Jimenez-Sanchez, G., Childs, B., and Valle, D. 2001. Human disease genes. Nature 409: 853-855.
17. Johnson, N.L. and Kotz, S. 1969. Discrete distributions. Wiley, New York.
18. Johnson, J.A. and Lima, J.J. 2003. Drug receptor/effector polymorphisms and pharmacogenetics: Current status and challenges. Pharmacogenetics 13: 525-534.
19. Noh, J.D. 2003. Exact scaling properties of a hierarchical network model. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 67: 045103.doi: 10.1103/PhysRevE.67.045103.
20. Peri, S., Navarro, J.D., Kristiansen, T.Z., Amanchy, R., Surendranath, V., Muthusamy, B., Gandhi, T.K., Chandrika, K.N., Deshpande, N., Suresh, S., et al. 2004. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res. 32: D497-D501.
21. Rual, J.F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G.F., Gibbons, F.D., Dreze, M., Ayivi-Guedehoussou, N., et al. 2005. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437: 1173-1178.
22. Rzhetsky, A., Iossifov, I., Koike, T., Krauthammer, M., Kra, P., Morris, M., Yu, H., Duboue, P.A., Weng, W., Wilbur, W.J., et al. 2004. GeneWays: A system for extracting, analyzing, visualizing, and integrating molecular pathway data. J. Biomed. Inform. 37: 43-53.
23. Schomburg, I., Chang, A., Ebeling, C., Gremse, M., Heldt, C., Huhn, G., and Schomburg, D. 2004. BRENDA, the enzyme database: Updates and major new developments. Nucleic Acids Res. 32: D431-D433.
24. Shannon, C.E. and Weaver, W. 1949. The mathematical theory of communication. University of Illinois Press, Urbana.
25. Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M., and Sirotkin, K. 2001. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 29: 308-311.
26. Stelzl, U., Worm, U., Lalowski, M., Haenig, C., Brembeck, F.H., Goehler, H., Stroedicke, M., Zenkner, M., Schoenherr, A., Koeppen, S., et al. 2005. A human protein-protein interaction network: A resource for annotating the proteome. Cell 122: 957-968.
27. Thomas, P.D., Campbell, M.J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A., and Narechania, A. 2003. PANTHER: A library of protein families and subfamilies indexed by function. Genome Res. 13: 2129-2141.
28. Wishart, D.S., Knox, C., Guo, A.C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., and Woolsey, J. 2006. DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34: D668-D672.
29. Witten, I.H. and Frank, E. 2005. Data mining: Practical machine learning tools and techniques. Morgan Kaufman, Amsterdam.
30. Zambrowicz, B.P. and Sands, A.T. 2003. Knockouts model the 100 best-selling drugs - Will they model the next 100? Nat. Rev. Drug Discov. 2: 38-51.
31. Zheng, C., Han, L., Yap, C.W., Xie, B., and Chen, Y. 2006. Progress and problems in the exploration of therapeutic targets. Drug Discov. Today 11: 412-420.